ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1088

Staff Protocol in Rheumatology Clinics Reduces Population-Level Rate of High Blood Pressure

Christie M. Bartels1, Edmond Ramly2, Emmanuel Sampene3, Diane Lauver4, Patrick McBride5 and Heather Johnson5, 1Rheumatology/Medicine, University of Wisconsin - Madison, Madison, WI, 2Industrial and Systems Engineering, University of Wisconsin College of Engineering, Madison, WI, 3Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4University of Wisconsin-Madison School of Nursing, Madison, WI, 5Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, Clinical practice, hypertension, population studies and prevention

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Measures and Measurement of Healthcare Quality Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The Centers for Disease Control and Prevention director has said “nothing will save more lives” than protocols to control blood pressure (BP). BP is relevant in rheumatology clinics because it is causally linked to cardiovascular disease. Hypertension control is also one of ten RA quality measures endorsed by ACR and Medicare for 2017 quality payment reporting. Yet, minimal evidence exists on how to improve BP control in busy rheumatology clinics. We previously implemented a staff protocol that doubled timely follow-up after high BPs in rheumatology clinics, and now aimed to examine its impact on population BP control.

Methods: We assessed population trends in the rate of monthly high BPs (% of all visits) before and after the implementation of a staff BP Connect Health protocol in three rheumatology clinics (10/2012-10/2014 vs. 11/2014-12/2016). During implementation, clinical educators trained nurses and medical assistants in an hour-long session on BP in rheumatic diseases, proper BP measurement, and the BP Connect Health protocol steps. Protocols included EHR prompts to re-measure high BPs, and if confirmed high, offer timely primary care follow-up. Follow-up orders automatically routed to scheduling staff for patients with in-network primary care, and printed on after visit materials for all patients. EHR data reported the monthly percentage of adult rheumatology clinic visits with an initial BP >140/90 mmHg.

We performed time series regression with Newey-West standard errors to examine changes in rates of high BPs in the 24 months before and after protocol implementation.

Results:   A total of 28,109 pre-protocol rheumatology clinic visits were compared to 28,285 visits after protocol implementation. Monthly rates of high BP, when averaged over the periods before and after implementation, fell from 17% pre- to 8% post-protocol.  Time series analysis demonstrated a significant reduction after protocol implementation and continued improvement over time (Figure 1. p<0.003 & p<0.03). Strengths included 2-year protocol feasibility; limitations include our single center pre-post design.

Conclusion:   After implementing the rheumatology staff protocol, we observed a 9% reduction in mean rates of high BP across rheumatology clinic populations.  Early improvements likely reflected staff BP training, while later improvements may reflect improved follow-up, adherence, and management of BP. Future multi-site studies will test the BP Connect Health protocol in other rheumatology and specialty populations at risk for cardiovascular disease.

Figure 1


Disclosure: C. M. Bartels, Pfizer Inc, 2; E. Ramly, None; E. Sampene, None; D. Lauver, None; P. McBride, None; H. Johnson, None.

To cite this abstract in AMA style:

Bartels CM, Ramly E, Sampene E, Lauver D, McBride P, Johnson H. Staff Protocol in Rheumatology Clinics Reduces Population-Level Rate of High Blood Pressure [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/staff-protocol-in-rheumatology-clinics-reduces-population-level-rate-of-high-blood-pressure/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/staff-protocol-in-rheumatology-clinics-reduces-population-level-rate-of-high-blood-pressure/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology